Enveric Biosciences (ENVB) Net Equity Issued and Repurchased (2013 - 2026)

Enveric Biosciences (ENVB) posted Net Equity Issued and Repurchased of $1.3 million for Q1 2026, up 150.74% sequentially from $517836.0 in Q3 2024.

Enveric Biosciences (ENVB) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends

Enveric Biosciences has reported Net Equity Issued and Repurchased for 10 years, with the latest figure at $1.3 million in Q1 2026.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed N/A YoY) and the FY2024 annual result came in at $2.3 million, changed N/A from the prior year.
Net Equity Issued and Repurchased rose to $1.3 million in Q1 2026 per ENVB's latest filing, from $517836.0 in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $9.4 million in Q1 2022 and troughed at -$1.0 in Q4 2022.
A 3-year average of $3.1 million and a median of $1.3 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
The widest YoY moves for Net Equity Issued and Repurchased: up 56.52% in 2022, down 56.52% in 2022.
Over 3 years, Net Equity Issued and Repurchased stood at -$1.0 in 2022, then surged by 51783700.0% to $517836.0 in 2024, then jumped by 150.74% to $1.3 million in 2026.
According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1.3 million, $517836.0, and $82850.0 for Q1 2026, Q3 2024, and Q2 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Enveric Biosciences	5.66 Mn	-2.64 Mn	-	-7,377.00

Download Data